For Investors
Investor Relations
The platform is live. Partner with us to accelerate the future of chemical synthesis.
Market Opportunity
The global drug discovery market is projected to reach $71B by 2030, with AI-powered solutions leading the transformation.
Experienced Team
Our leadership combines deep expertise in machine learning, synthetic chemistry, and corporate development.
Validated Technology
Experimentally validated retrosynthesis across diverse molecular structures, grounded in peer-reviewed research.
Strong IP Position
Built on peer-reviewed research and exclusively licensed methods spanning route generation, multi-objective scoring, and synthesis condition prediction.